News

Cortex To Hold Annual Shareholder Meeting on May 19 at Marriott Newport Beach Hotel in Newport Beach, CA

— Live Webcast Available at www.cortexpharm.com —

IRVINE, CA (May 14, 2010) — Cortex Pharmaceuticals, Inc. (OTCBB (CORX)) will webcast presentations from its annual shareholder meeting scheduled for Wednesday, May 19, 2010, at 10:30 a.m., Pacific Daylight Time, at the Marriott Newport Beach Hotel, 900 Newport Center Drive, in Newport Beach, California.

The meeting will begin with the formal voting on the issues set forth in the proxy statement. In the informal part of the meeting, Dr. Mark A. Varney, President and CEO, will update shareholders on the company’s activities.

Investors may access the live webcast through the Cortex website at http://www.cortexpharm.com/ beginning at 10:30 a.m. Pacific Daylight Time on May 19, 2010. The webcast will be available for replay for 30 days.

Cortex Pharmaceuticals, Inc.
Cortex, located in Irvine, California, is a neuroscience company focused on novel drug therapies for treating psychiatric disorders, neurological diseases and sleep apnea. Cortex is pioneering a class of proprietary pharmaceuticals called Ampakine® compounds, which act to increase the strength of signals at connections between brain cells. The loss of these connections is thought to be responsible for memory and behavior problems in Alzheimer’s disease. Many psychiatric diseases, including schizophrenia, occur as a result of imbalances in the brain’s neurotransmitter system. These imbalances may be improved by using the Ampakine technology. For additional information regarding Cortex, please visit the Company’s website at http://www.cortexpharm.com

Contacts:

Company Contact:
Mark A. Varney, Ph.D.
President ad CEO
Cortex Pharmaceuticals, Inc.
949.727.3157

Investor Contact:
Erika Moran/Dian Griesel, Ph.D.
Media Contact:
Janet Vasquez
The Investor Relations Group
212.825.3210